Back to search
Short Gut Syndrome
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Short Gut Syndrome trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Short Gut Syndrome trials you may qualify forThis is a randomized, double-blind, placebo-controlled, proof-of-concept (PoC), Phase 2 study to assess the safety, PK, and PD of SC administration of HM15912(s…
Eligible patients were randomized into two groups: the GLP-1 group and the control group. The control group received a placebo along with standard care, without…
The purpose of the present Phase 3 trial is to confirm the efficacy and safety of glepaglutide 10 mg twice weekly in a patient population with SBS-IF and genera…
This study proposes to quantify and describe the quality of life of children with intestinal failure, and to identify the medical and socio-economic factors tha…
Short Bowel Syndrome (SBS) is a rare condition that happens when a large part of the bowel (also called intestine) is missing or has been removed because of ill…
The main aim of this clinical trial is to assess the efficacy and safety of PJ009 in patients aged ≥14 with short bowel syndrome (SBS) requiring parenteral nutr…
This prospective and observational study aims to evaluate the accumulation of advanced glycation end-products (AGEs) in adult and pediatric patients starting lo…
This is a randomized controlled, parallel group, open label versus "no treatment" trial which evaluate the efficacy of rhGH on weaning off parenteral nutrition…
During the first years following intestinal resection, spontaneous physiological adaptations occur in patients with short bowel syndrome (SBS), allowing improve…